Control of Gene Expression by Catecholamines and the Renin-Angiotensin System. This item is unavailable.
Language: English
Published by Springer, 2000
- Hardcover
- New

Seller: Majestic Books, Hounslow, United KingdomMajestic Books
4-star seller
AbeBooks seller since January 19, 2007
Unavailable
Hardcover
Condition: New
£ 228.02
Item description from seller
pp. 239 Illus.
Seller Inventory # 5676023
- Title
- Control of Gene Expression by Catecholamines and the Renin-Angiotensin System
- Publisher
- Springer
- Publication year
- 2000
- Condition
- New
- Binding
- Hardcover
- Language
- English
- ISBN 10
- 0792379810
- ISBN 13
- 9780792379812
The special issue of "Molecular and Cellular Biochemistry" focuses on "Control of Gene Expression by Catecholamines and the Renin-Angiotensin System" in health and disease. In the 1990s great progress was made in the understanding of catecholamine- and angiotensin II-modulated gene expression. There is also increasing evidence that catecholamine and angiotensin II induced cellular injury arises not solely from classical pathways, but also from a perturbed gene expression. Taking into account that catecholamines and angiotensin II are vital for a balanced gene expression of many cells, the intriguing possibility arises that various disease are initiated or aggravated by such an imbalance. Catecholamine and angiotensin II influences can be in excess arising from, for example, hypercaloric food intake or psychosocial stress. During early progression of heart failure, sympathetic activity and angiotensin II influences also become increased. Due to beta-adrenergic receptor downregulation, depressed catecholamine influences are expected in the final stage of heart failure. An imbalanced influence of catecholamines and angiotensin II on gene expression leads to disordered molecular structures of the cell and an impaired cell function. This focused issue is organized into chapters concentrating on catecholamines, angiotensin II, and the interaction between catecholamines and angiotensin II. Basic biochemical processes are covered in detail and the potential of these pathways for explaining chronic diseases associated with excess catecholamine and angiotensin II influences should become apparent. It is hoped that this focused issue will trigger novel research into the development of drugs that are targeted at diseases characterized by an imbalanced gene expression involving catecholamines and angiotensin II.
"Synopsis" may belong to another edition of this title.
Synopsis
The special issue of "Molecular and Cellular Biochemistry" focuses on "Control of Gene Expression by Catecholamines and the Renin-Angiotensin System" in health and disease. In the 1990s great progress was made in the understanding of catecholamine- and angiotensin II-modulated gene expression. There is also increasing evidence that catecholamine and angiotensin II induced cellular injury arises not solely from classical pathways, but also from a perturbed gene expression. Taking into account that catecholamines and angiotensin II are vital for a balanced gene expression of many cells, the intriguing possibility arises that various disease are initiated or aggravated by such an imbalance. Catecholamine and angiotensin II influences can be in excess arising from, for example, hypercaloric food intake or psychosocial stress. During early progression of heart failure, sympathetic activity and angiotensin II influences also become increased. Due to beta-adrenergic receptor downregulation, depressed catecholamine influences are expected in the final stage of heart failure.
An imbalanced influence of catecholamines and angiotensin II on gene expression leads to disordered molecular structures of the cell and an impaired cell function. This focused issue is organized into chapters concentrating on catecholamines, angiotensin II, and the interaction between catecholamines and angiotensin II. Basic biochemical processes are covered in detail and the potential of these pathways for explaining chronic diseases associated with excess catecholamine and angiotensin II influences should become apparent. It is hoped that this focused issue will trigger novel research into the development of drugs that are targeted at diseases characterized by an imbalanced gene expression involving catecholamines and angiotensin II.
"About the title" may belong to another edition of this title.